Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Emerging mRNA technology for liver disease therapy
J Wang, Y Fang, Z Luo, J Wang, Y Zhao - ACS nano, 2024 - ACS Publications
Liver diseases have consistently posed substantial challenges to global health. It is crucial
to find innovative methods to effectively prevent and treat these diseases. In recent times …
to find innovative methods to effectively prevent and treat these diseases. In recent times …
New thiazolidine-2, 4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies
Background VEGFR-2 has emerged as a prominent positive regulator of cancer
progression. Aim Discovery of new anticancer agents and apoptotic inducers targeting …
progression. Aim Discovery of new anticancer agents and apoptotic inducers targeting …
Inhibition of hepatocellular carcinoma progression by methotrexate-modified pH-sensitive sorafenib and schisandrin B micelles
Y Yan, L Kong, Y Lu, S Li, A Yan, Y Song… - Biomedical …, 2024 - iopscience.iop.org
Due to the lack of specific symptoms, hepatocellular carcinoma (HCC) is often detected in
advanced stages. However, pharmacological systemic therapy, a common clinical treatment …
advanced stages. However, pharmacological systemic therapy, a common clinical treatment …